Establishing a Comprehensive Questionnaire for Detecting Drug-induced Extrapyramidal Symptoms

• Published in: YAKUGAKU ZASSHI Vol. 123; no. 10; pp. 881 - 886
• Main Authors: ITOH, Atsuo, OHNO, Keiko, MIYAZAWA, Shinsuke, HASHIGUCHI, Masayuki, UNEMOTO, Tamao, RIKIHISA, Tadaaki, OGATA, Hiroyasu, ECHIZEN, Hirotoshi, MURATA, Masahiro
• Format: Journal Article
• Language: English
• Published: Japan The Pharmaceutical Society of Japan 01.10.2003
• Subjects: adverse drug reactions; Aged; Basal Ganglia Diseases - chemically induced; Basal Ganglia Diseases - diagnosis; Benzamides - adverse effects; Benzyl Compounds - adverse effects; Cisapride - adverse effects; Domperidone - adverse effects; Dopamine Antagonists - adverse effects; drug-induced extrapyramidal symptoms; Female; Gastrointestinal Agents - adverse effects; Humans; Male; Metoclopramide - adverse effects; Middle Aged; pharmaceutical care; questionnaire; Surveys and Questionnaires; Trimebutine - adverse effects
• ISSN: 0031-6903; 1347-5231; 1347-5231
• DOI: 10.1248/yakushi.123.881

Objective: Drug-induced extrapyramidal symptoms (DIEPS) often substantially compromise quality of life (QOL) of patients receiving drugs with central antidopaminergic activities. A lack of comprehensive screening method based upon patients' subjective symptoms for detecting DIEPS appears to have prevented pharmacists from delivering satisfactory pharmaceutical care for these patients. Thus, we have attempted to develop a comprehensive questionnaire for screening patients having higher risks of developing DIEPS. Methods: One hundred fourteen outpatients taking gastroprokinetic drugs (itopride, cisapride, trimebutine, domperidone and metoclopramide) at least 2 weeks participated in the study. One patient with familial Parkinson disease served as a positive reference. They undertook a questionnaire consisting of 9 comprehensive questions written in non-technical words that were aimed to detect typical symptoms of Parkinsonism including akathisia and dyskinesia. Each symptom was scored in a semiquantitative scale [i.e., from 1 (not at all) to 5 (very much)] by the patients. Results: Of the 108 subjects who successfully completed the questionnaires, 43 gave scores 2 or greater indicating the presence of DIEPS. However, no statistically significant correlations were observed between the scores of any possible pairs of the questionnaire items. Five subjects had a mean questionnaire score of equal to or greater than 1.6, and the patient with familiar Parkinsonism had the highest mean score of 1.9. Conclusion: The questionnaire presented herein detected 4 patients with suspected DIEPS. Further studies should be warranted to assess whether it would be useful for pharmacists as a screening tool for DIEPS in patients having higher risks of DIEPS.